Your Weekly Dose of News in Pharma, Biotech and Health

In global health, efforts are underway to rekindle vaccine leadership in the EU, while the fight against AIDS, TB, and malaria faces challenges due to climate change. In marketing, Novartis employs sculptures to raise awareness of cancer symptoms, and Gilead Sciences publishes a unique, difficult-to-read book to highlight marginalized patients. In the MedTech sector, Mayo Clinic and GE Healthcare collaborate on tech-driven theranostic imaging. A survey reveals that most pharmaceutical companies are not adequately prepared for future challenges like AI advances and IRA legislation. In politics, President Biden's Cancer Moonshot initiatives are scrutinized, and Ursula von der Leyen's health remarks in a European Union speech draw attention. The Biden administration takes on the US drugs industry, and in regulatory news, the FDA proposes changes to a key approval pathway for medical devices, five years after making promises to do so.

Photo credit: Gilead Sciences

Global Health

Reigniting vaccine leadership in the EU

by Politico

Climate change impeding fight against AIDS, TB and malaria

by Reuters


Novartis makes sculptures to shape knowledge of cancer symptoms

by Fierce Pharma

Gilead Sciences opens a new chapter, publishes the world's 'hardest book to read' to reveal patients stuck in the margins

by Fierce Pharma


Mayo Clinic, GE HealthCare launch tech-driven theranostic imaging collaboration

by Fierce Biotech


Most pharma companies are not ‘future ready’ as pressure mounts from AI advances and IRA legislation, survey finds

by Endpoints News


What to make of Biden’s latest Cancer Moonshot efforts


Von der Leyen accidentally went up against Biden on health — and lost

by Politico

The Biden administration takes on the US drugs industry

by Financial Times 


FDA proposes changes to key approval pathway for medical devices, five years after promising


For an overview of previous Weekly Notables, visit our Archive

Leave a comment